Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease

Data suggest that adjuvant human papillomavirus (HPV)-vaccination in women treated for cervical HPV diseases reduces recurrent disease. This study investigates adjuvant HPV-vaccination and the rate of recurrence in women undergoing surgery for vulvar high-grade squamous intraepithelial lesions (HSIL...

Full description

Bibliographic Details
Main Authors: Alessandro Ghelardi, Roberto Marrai, Giorgio Bogani, Francesco Sopracordevole, Paola Bay, Arianna Tonetti, Stefania Lombardi, Gloria Bertacca, Elmar A. Joura
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Vaccines
Subjects:
HPV vaccination
adjuvant HPV vaccination
vulvar HSIL
vulvar HSIL treatment
Online Access:https://www.mdpi.com/2076-393X/9/2/83

Internet

https://www.mdpi.com/2076-393X/9/2/83

Similar Items